Trial Profile
A Sequential, Randomized, Double-blind, Placebo-controlled, Prospective Study to Evaluate the Safety and Efficacy of the H-100 Treatment in Adult Male Volunteers With Peyronie's Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs H 100 (Primary)
- Indications Peyronie's disease
- Focus Adverse reactions
- Sponsors Hybrid Medical
- 19 Mar 2014 New trial record